This inventor holds 3 USPTO granted patents. Top assignee: American Cyanamid Company. Active years: 1980-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pearl River, NY (US) (1980)
- New City, NY (US) (1982)
Company Filing History:
Years Active: 1980-1982
Title: The Innovations of John J Brown
Introduction
John J Brown is a notable inventor based in Pearl River, NY (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing compounds that serve as analgesic and neuroleptic agents.
Latest Patents
Among his latest patents is the invention of 4-Aryl-1-oxa-8-azaspiro[4,5]dec-3-en-2-ones. This disclosure describes 8-substituted-4-phenyl-1-oxa-8-azaspiro[4,5]dec-3-en-2-ones and 8-substituted-4-phenyl-1-oxa-8-azaspiro[4,5]decan-2-ones, which are useful as analgesic or neuroleptic agents. Another significant patent is for 11-(1,2,3,6-Tetrahydro-substituted-4-pyridyl)-dibenz[b,f][1,4]oxazepines. This invention includes unsubstituted, mono-, di-, or trisubstituted-11-(1,2,3,6-tetrahydro-substituted-4-pyridyl)-dibenz[b,f][1,4]oxazepines, which are useful as anti-psychotic agents.
Career Highlights
John J Brown is currently associated with the American Cyanamid Company, where he continues to innovate and develop new pharmaceutical compounds. His work has had a significant impact on the field, particularly in the development of medications that address critical health issues.
Collaborations
Throughout his career, John has collaborated with notable coworkers such as Thomas C McKenzie and Lantz S Crawley. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
John J Brown's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of important medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile